Cite
Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
MLA
Rosalind J Carter, et al. “Pregnancy Outcomes among Women Receiving RVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.” Emerging Infectious Diseases, vol. 26, no. 3, Jan. 2020, pp. 541–48. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....818a2db6896f2b9900a39465fbc0ba10&authtype=sso&custid=ns315887.
APA
Rosalind J Carter, Olamide D Jarrett, Elena Szefer, Barbara E. Mahon, Mohamed Samai, Susan T. Goldstein, Sarah C. Tinker, Jennifer Legardy-Williams, & Augustin E Fombah. (2020). Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola. Emerging Infectious Diseases, 26(3), 541–548.
Chicago
Rosalind J Carter, Olamide D Jarrett, Elena Szefer, Barbara E. Mahon, Mohamed Samai, Susan T. Goldstein, Sarah C. Tinker, Jennifer Legardy-Williams, and Augustin E Fombah. 2020. “Pregnancy Outcomes among Women Receiving RVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.” Emerging Infectious Diseases 26 (3): 541–48. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....818a2db6896f2b9900a39465fbc0ba10&authtype=sso&custid=ns315887.